P. Jaquet

发表

Novel modalities of somatostatin actions.

J. Fombonne, S. Krantic, A. Enjalbert, 2004, European journal of endocrinology.

Abnormal transduction mechanisms in pituitary adenomas.

A. Barlier, L. Caccavelli, A. Enjalbert, 1997, Hormone research.

Relevance of coexpression of somatostatin and dopamine D2 receptors in pituitary adenomas

A. Barlier, T. Brue, A. Saveanu, 2008, Molecular and Cellular Endocrinology.

D2 dopaminergic receptors: normal and abnormal transduction mechanisms.

D. Cussac, V. Audinot, L. Caccavelli, 1992, Hormone research.

Decreased expression of the two D2 dopamine receptor isoforms in bromocriptine-resistant prolactinomas.

R. Benarous, E. Rouer, F. Féron, 1994, Neuroendocrinology.

[Therapeutic strategies in somatotroph adenomas with extrasellar extension: role of the medical approach, a consensus study of the French Acromegaly Registry].

G. Sassolas, P. Chanson, J. Régis, 2003, Annales d'endocrinologie.

Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease.

I. Morange, T. Brue, F. Castinetti, 2008, European journal of endocrinology.

The analysis of quantitative expression of somatostatin and dopamine receptors in gastro-entero-pancreatic tumours opens new therapeutic strategies.

A. Barlier, P. Ruszniewski, A. Couvelard, 2006, European journal of endocrinology.

Severe fibromyalgia after hypophysectomy for Cushing's disease.

P. Disdier, P. Weiller, T. Brue, 1991, Arthritis and rheumatism.

Diagnosis and treatment of acromegaly complications

P. Chanson, F. Casanueva, M. Vance, 2003, Journal of endocrinological investigation.

Desmopressin test during petrosal sinus sampling: a valuable tool to discriminate pituitary or ectopic ACTH-dependent Cushing's syndrome.

N. Girard, H. Dufour, I. Morange, 2007, European journal of endocrinology.

Characterization of corticotropin-releasing hormone receptors on human pituitary corticotroph adenomas and their correlation with endogenous glucocorticoids.

C. Oliver, A. Margioris, M. Grino, 1988, The Journal of clinical endocrinology and metabolism.

Somatostatin and Dopamine-Somatostatin Multiple Ligands Directed towards Somatostatin and Dopamine Receptors in Pituitary Adenomas

M. Culler, H. Dufour, A. Saveanu, 2006, Neuroendocrinology.

Somatostatin–dopamine ligands in the treatment of pituitary adenomas

A. Saveanu, P. Jaquet, 2009, Reviews in Endocrine and Metabolic Disorders.

Novel chimeric somatostatin analogs: facts and perspectives.

M. Culler, F. Minuto, D. Ferone, 2007, European journal of endocrinology.

A potential inhibitory role for the new truncated variant of somatostatin receptor 5, sst5TMD4, in pituitary adenomas poorly responsive to somatostatin analogs.

M. Malagón, M. Culler, A. Barlier, 2010, The Journal of clinical endocrinology and metabolism.

Efficacy of a dopamine-somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center study.

M. Culler, G. Stalla, M. Theodoropoulou, 2008, Endocrine-related cancer.

The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society BIM-23244, a Somatostatin Receptor Subtype 2- and 5- Selective Analog with Enhanced Efficacy in Suppressing Growth Hormone (GH) from Octreotide-

P. Caron, M. Culler, L. Ouafik, 2022 .

A luteinizing hormone-, alpha-subunit- and prolactin-secreting pituitary adenoma responsive to somatostatin analogs: in vivo and in vitro studies.

H. Dufour, A. Enjalbert, A. Saveanu, 2001, European journal of endocrinology.

Pronostic and Therapeutic Consequences of Gsα Mutations in Somatotroph Adenomas1

D. Figarella-Branger, A. Barlier, A. J. Zamora, 1998 .

Impact of gsp oncogene on the expression of genes coding for Gsalpha, Pit-1, Gi2alpha, and somatostatin receptor 2 in human somatotroph adenomas: involvement in octreotide sensitivity.

A. Barlier, A. J. Zamora, A. Enjalbert, 1999, The Journal of clinical endocrinology and metabolism.

Cell growth inhibition and functioning of human somatostatin receptor type 2 are modulated by receptor heterodimerization.

U. Kumar, M. Grant, P. Jaquet, 2008, Molecular endocrinology.

Rapid pituitary tumor shrinkage with dissociation between antiproliferative and antisecretory effects of a long-acting octreotide in an acromegalic patient.

M. Culler, F. Minuto, D. Ferone, 2007, The Journal of clinical endocrinology and metabolism.

Demonstration of enhanced potency of a chimeric somatostatin-dopamine molecule, BIM-23A387, in suppressing growth hormone and prolactin secretion from human pituitary somatotroph adenoma cells.

J. Taylor, M. Culler, A. Barlier, 2002, The Journal of clinical endocrinology and metabolism.

Three year follow-up of acromegalic patients treated with intramuscular slow-release lanreotide.

P. Caron, P. Jaquet, I. Morange-Ramos, 1997, The Journal of clinical endocrinology and metabolism.

Somatostatinergic ligands in dopamine-sensitive and -resistant prolactinomas.

M. Culler, A. Barlier, H. Dufour, 2008, European journal of endocrinology.

Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapy.

J. Taylor, M. Culler, H. Dufour, 2005, European journal of endocrinology.

BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotide.

J. Taylor, M. Culler, A. Barlier, 2005, Journal of endocrinological investigation.

Somatostatin receptors, adenylate cyclase activity, and growth hormone (GH) response to octreotide in GH-secreting adenomas.

P. Chanson, J. Bertherat, F. Peillon, 1993, The Journal of clinical endocrinology and metabolism.

Sandostatin LAR®: Pharmacokinetics, pharmacodynamics, efficacy, and tolerability in acromegalic patients

I. Lancranjan, S. Lamberts, P. Kendall‐Taylor, 1995 .

Sandostatin LAR: a promising therapeutic tool in the management of acromegalic patients.

I. Lancranjan, H. Orskov, S. Lamberts, 1996, Metabolism: clinical and experimental.

Resistance to bromocriptine in prolactinomas.

F. Peillon, C. Jedynak, I. Pellegrini, 1989, The Journal of clinical endocrinology and metabolism.

The electrical properties of isolated human prolactin-secreting adenoma cells and their modification by dopamine.

J. Vincent, J. Israel, P. Jaquet, 1985, Endocrinology.

3D-FT thin sections MRI of prolactin-secreting pituitary microadenomas

N. Girard, C. Raybaud, T. Brue, 1994, Neuroradiology.

GH deficiency in adults: an epidemiological approach.

G. Sassolas, P. Chanson, J. Bringer, 1999, European journal of endocrinology.

Different pathways of secretion for glycosylated and nonglycosylated human prolactin.

I. Pellegrini, F. Grisoli, P. Jaquet, 1990, Endocrinology.

Alteration of Gα Subunits mRNA Levels in Bromocriptine Resistant Prolactinomas

L. Caccavelli, A. Enjalbert, C. Kordon, 1996 .

The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Quantitative and Functional Expression of Somatostatin Receptor Subtypes in Human Prolactinomas*

M. Culler, L. Ouafik, H. Dufour, 2022 .

Pit-1 gene expression in human lactotroph and somatotroph pituitary adenomas is correlated to D2 receptor gene expression.

D. Figarella-Branger, A. Barlier, A. Enjalbert, 1996, The Journal of clinical endocrinology and metabolism.

[Familial primary empty sella turcica. Apropos of a family with 3 cases].

P. Jaquet, M. Heim, S. Colliot, 1990, Annales d'endocrinologie.

Effects of TRH and Bromocriptine in Acromegaly: In Vivo and in Vitro Studies

E. Goldstein, F. Grisoli, P. Jaquet, 1980 .

Prolactin secreting tumors. Endocrine status before and after surgery in 33 women.

J. Lissitzky, P. Carayon, F. Grisoli, 1978, The Journal of clinical endocrinology and metabolism.

Immunoreactive somatostatin in rat hypophysial portal blood.

P. Giraud, C. Oliver, P. Jaquet, 1979, Endocrinology.

Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions.

J. Bertherat, J. Epelbaum, T. Brue, 1992, The Journal of clinical endocrinology and metabolism.

Resistance to Bromocriptine in Prolactinomas

F. Peillon, C. Jedynak, I. Pellegrini, 1990 .

Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation.

M. Culler, F. Minuto, John E. Taylor, 2005, American journal of physiology. Endocrinology and metabolism.

Culture of dispersed anterior pituitary cells on extracellular matrix.

J. Ramsdell, C. Bethea, R. Weiner, 1983, Methods in enzymology.

Direct action of opiates on bromocriptine-inhibited prolactin release by human prolactinoma cells in primary culture.

P. Giraud, E. Castanas, P. Jaquet, 1985, The Journal of clinical endocrinology and metabolism.

A new mutation of the gene encoding the transcription factor Pit-1 is responsible for combined pituitary hormone deficiency.

A. Barlier, P. Belicar, B. Vialettes, 1996, The Journal of clinical endocrinology and metabolism.

Expression of the members of the Ptx family of transcription factors in human pituitary adenomas.

D. Figarella-Branger, A. J. Zamora, M. Grino, 1999, The Journal of clinical endocrinology and metabolism.

Consensus statement: medical management of acromegaly.

P. Chanson, E. Laws, F. Casanueva, 2005, European journal of endocrinology.

Polymorphism of prolactin secreted by human prolactinoma cells: immunological, receptor binding, and biological properties of the glycosylated and nonglycosylated forms.

J. Peyrat, E. Fenouillet, I. Pellegrini, 1988, Endocrinology.

Polymorphism of thyrotropin and alpha subunit in human pituitary adenomas

G. Medri, C. Ronin, P. Jaquet, 1993, Journal of endocrinological investigation.

Macroprolactinemia revisited: a study on 106 patients.

T. Brue, A. Enjalbert, Adel I. Selim, 2002, The Journal of clinical endocrinology and metabolism.

Immunoradiometric analysis of circulating human glycosylated and nonglycosylated prolactin forms: spontaneous and stimulated secretions.

T. Hoffmann, I. Morange, T. Brue, 1992, The Journal of clinical endocrinology and metabolism.

Hormonal regulation of prolactin release by human prolactinoma cells cultured in serum-free conditions.

F. Grisoli, P. Jaquet, G. Gunz, 1985, Hormone Research.

Quinagolide--a valuable treatment option for hyperprolactinaemia.

A. Barlier, P. Jaquet, 2006, European journal of endocrinology.

A human pituitary adenoma secreting thyrotropin and prolactin: immunohistochemical, biochemical, and cell culture studies.

B. Weintraub, J. Hassoun, F. Grisoli, 1984, The Journal of clinical endocrinology and metabolism.

Enzymatic radioiodination of porcine thyroid-stimulating hormone.

G. Hennen, S. Lissitzky, P. Jaquet, 1974, Biochimie.

Thyroid‐stimulating hormone binding to cultured thyroid cells

B. Verrier, G. Hennen, S. Lissitzky, 1973, FEBS letters.

Prolactin isoforms secreted by human prolactinomas.

T. Hoffmann, T. Brue, C. Ronin, 1992, Hormone research.

Prolactinomas and resistance to dopamine agonists.

I. Morange, T. Brue, I. Pellegrini, 1992, Hormone research.

The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Human Somatostatin Receptor Subtypes in Acromegaly: Distinct Patterns of Messenger Ribonucleic Acid Expression and Hormone Suppression Identify

M. Culler, A. J. Zamora, L. Ouafik, 2022 .

Pronostic and therapeutic consequences of Gs alpha mutations in somatotroph adenomas.

D. Figarella-Branger, A. Barlier, A. J. Zamora, 1998, The Journal of clinical endocrinology and metabolism.

Effects of the dopamine agonist CV 205-502 in human prolactinomas resistant to bromocriptine.

D. Dewailly, I. Morange, T. Brue, 1992, The Journal of clinical endocrinology and metabolism.

Prolactinomas resistant to bromocriptine: long-term efficacy of quinagolide and outcome of pregnancy.

A. Barlier, I. Morange, T. Brue, 1996, European journal of endocrinology.

An ultrarapid prognostic index in microprolactinoma surgery.

R. Guieu, H. Dufour, H. Rochat, 1999, Journal of neurosurgery.

Chirurgie des prolactinomes

H. Dufour, T. Brue, P. Jaquet, 2007 .

Short-Term Endocrinological Results after Gamma Knife Surgery of Pituitary Adenomas

J. Régis, J. Peragut, H. Dufour, 1998, Stereotactic and Functional Neurosurgery.

Enlarged adenomectomy for enclosed prolactinomas: A preliminary study of 26 cases

R. Costa, J. Trouillas, T. Brue, 2005, Acta Neurochirurgica.

[Interactions between prolactin with its receptor].

I. Pellegrini, P. Jaquet, 1989, Annales d'endocrinologie.

Gamma-Knife Surgery for Secreting Pituitary Adenomas

J. Régis, J. Peragut, H. Dufour, 1998, Acta Neurochirurgica.

Pit-1 gene expression in the human pituitary and pituitary adenomas.

D. Figarella-Branger, A. Barlier, I. Pellegrini, 1994, The Journal of clinical endocrinology and metabolism.

In vitro corticotropin-releasing hormone (CRH) stimulation of adrenocorticotropin release from corticotroph adenoma cells: effect of prolonged exposure to CRH and its interaction with cortisol.

C. Oliver, M. Grino, F. Grisoli, 1988, The Journal of clinical endocrinology and metabolism.

[Antitumor effect of bromocriptine in 5 cases of invasive prolactinoma].

F. Grisoli, P. Jaquet, M. Guibout, 1982, Annales de medecine interne.

Gamma knife radiosurgery is a successful adjunctive treatment in Cushing's disease.

J. Régis, J. Régis, H. Dufour, 2007, European journal of endocrinology.

Immunohistochemical and immunoelectron-microscopic study of pituitary adenomas associated with Cushing's disease. A report of 13 cases.

C. Oliver, J. Hassoun, C. Charpin, 1982, The American journal of pathology.

The desmopressin test as a predictive factor of outcome after pituitary surgery for Cushing's disease.

R. Valéro, T. Brue, P. Jaquet, 2004, European journal of endocrinology.

Markers of tumor invasion are major predictive factors for the long-term outcome of corticotroph microadenomas treated by transsphenoidal adenomectomy.

N. Girard, P. Caron, H. Dufour, 2000, European journal of endocrinology.

Immunohistochemica1 and Immunoelectron-Microscopic Study of Pituitary Adenomas Associated With Cushing's Disease A Report of 13 Cases

J. Hassoun, F. Grisoli, C. Oliver, 2007 .

Thyroid-Stimulating Hormone and Hyperthyroidism Pituitary Adenomas

J. Hassoun, F. Grisoli, P. Jaquet, 1986 .

[Prolactin adenoma in a 14-year-old boy].

Y. Morel, F. Grisoli, P. Jaquet, 1985, Pediatrie.

Bromocriptine effects on cultured human prolactin-producing pituitary adenomas: in vitro ultrastructural, morphometric, and immunoelectron microscopic studies.

J. Hassoun, F. Grisoli, B. Devictor, 1985, The Journal of clinical endocrinology and metabolism.

A long-acting repeatable form of bromocriptine as long-term treatment of prolactin-secreting macroadenomas: a multicenter study.

I. Lancranjan, J. Louvet, P. Roger, 1992, Fertility and sterility.

Alteration of G alpha subunits mRNA levels in bromocriptine resistant prolactinomas.

L. Caccavelli, A. Enjalbert, C. Kordon, 1996, Journal of neuroendocrinology.

Transsphenoidal surgery for acromegaly--long-term results in 100 patients.

J. Hassoun, F. Grisoli, P. Jaquet, 1985, Surgical neurology.

Slow release lanreotide treatment in acromegalic patients previously normalized by octreotide.

P. Chanson, D. Dewailly, I. Morange, 1994, The Journal of clinical endocrinology and metabolism.

PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency.

C. Teinturier, A. Barlier, J. Chaussain, 2001, The Journal of clinical endocrinology and metabolism.

The hormonal response to stress is not modified by the dramatic decrease in prolactin plasma concentration during surgery for microprolactinoma

R. Guieu, H. Dufour, H. Rochat, 1998, Journal of neurology, neurosurgery, and psychiatry.

Prolactin secreting adenoma in 22 men.

J. Hassoun, F. Grisoli, P. Jaquet, 1980, Surgical neurology.

[Diagnostic value of autoantibodies to MAG by ELISA Bühlmann in 117 immune-mediated peripheral neuropathies associated with monoclonal IgM to SGPG/SGLPG].

J. Antoine, P. Gonnaud, P. Petiot, 2006, Annales de biologie clinique.

Outcome of gamma knife radiosurgery in 82 patients with acromegaly: correlation with initial hypersecretion.

P. Chanson, J. Régis, M. Tamura, 2005, The Journal of clinical endocrinology and metabolism.

[Transcription factors of the anterior pituitary and combined hypopituitarism].

T. Brue, A. Enjalbert, S. Vallette, 1999, Annales d'endocrinologie.

Corticolipotropin immunoreactivity in silent chromophobe adenomas: a light and electron microscopic study.

J. Lissitzky, J. Hassoun, C. Charpin, 1982, Archives of pathology & laboratory medicine.

Variable growth hormone profiles following withdrawal of long-term 30mg slow-release lanreotide treatment in acromegalic patients: clinical implications.

P. Chanson, A. Tabarin, P. Caron, 2000, European journal of endocrinology.

[Long acting sandostatine (sandostatine LAR) in the treatment of acromegaly].

I. Lancranjan, P. Roger, P. Jaquet, 1995, Annales d'Endocrinologie.

Circadian regulation of growth hormone secretion after treatment in acromegaly.

F. Grisoli, P. Jaquet, J. Bert, 1980, The Journal of clinical endocrinology and metabolism.

Evidence for dopamine agonists in the treatment of acromegaly.

P. Jaquet, 1997, The Journal of endocrinology.

Long term treatment with the somatostatin analog SMS 201-995 in a patient with a thyrotropin- and growth hormone-secreting pituitary adenoma.

M. Decoulx, J. Wemeau, D. Dewailly, 1988, The Journal of clinical endocrinology and metabolism.

Damaging Effect of Therapeutic Radiation on Programmable Pacemakers

J. Niederer, R Adamec, J M Haefliger, 1982, Pacing and clinical electrophysiology : PACE.

[Pituitary tumor syndrome and hyperprolactinemia in peripheral hypothyroidism].

N. Girard, I. Morange, T. Brue, 1992, Annales d'endocrinologie.

Abnormal dopamine sensitivity in some human prolactinomas.

R. Costa, I. Pellegrini, F. Grisoli, 1989, Hormone research.

Enkephalins in human pheochromocytoma biosynthesis and secretion.

P. Giraud, E. Castanas, C. Oliver, 1982, European Heart Journal.

Long-term culture of human corticotropin-secreting adenomas on extracellular matrix and evaluation of serum-free conditions

M. Westphal, C. Wilson, P. Jaquet, 1986, Acta Neuropathologica.

Thyroid-stimulating hormone pituitary adenomas and hyperthyroidism.

J. Hassoun, F. Grisoli, P. Jaquet, 1986, Surgical neurology.

Resistance to somatostatin (SRIH) analog therapy in acromegaly. Re-evaluation of the correlation between the SRIH receptor status of the pituitary tumor and the in vivo inhibition of GH secretion in response to SRIH analog.

P. Chanson, J. Bertherat, J. Timsit, 1992, Hormone research.

Long-term culture of human corticotropin-secreting adenomas on extracellular matrix and evaluation of serum-free conditions

Charles B. Wilson, M. Westphal, P. Jaquet, 2004, Acta Neuropathologica.

Long-term culture of human corticotropin-secreting adenomas on extracellular matrix and evaluation of serum-free conditions. Secretory aspects.

M. Westphal, C. Wilson, P. Jaquet, 1986, Acta Neuropathologica.

Prolactinoma surgery.

H. Dufour, T. Brue, P. Jaquet, 2007, Annales d'Endocrinologie.

Plasma immunoreactive T3, TSH and ACTH before and after provocative tests in idiopathic hypopituitary dwarfism.

C. Carella, C. Oliver, G. Lombardi, 1975, The Journal of clinical endocrinology and metabolism.

Hormonal Rhythms in Pituitary Tumors

E. Castanas, E. Goldstein, F. Grisoli, 1981 .

[Proceedings: Effects of long term administration of thyrotropin-releasing hormone in the baboon (author's transl)].

P. Carayon, P. Jaquet, G. Strauch, 1974, Annales d'endocrinologie.

Noninactivation of thyrotropin by cultured porcine thyroid cells.

P. Jaquet, S. Hovsépian, G. Fayer, 1978, Biochimica et biophysica acta.

[Surgical results in prolactin-secreting pituitary adenomas (a propos of 40 personal observations)].

J. Hassoun, F. Grisoli, P. Jaquet, 1977, Neuro-chirurgie.

[Prolactin adenomas in children (author's transl)].

F. Giraud, F. Grisoli, P. Jaquet, 1980, Archives francaises de pediatrie.

Gamma knife radiosurgery is a successful adjunctive treatment in Cushing's disease.

J. Régis, H. Dufour, I. Morange, 2007, European journal of endocrinology.

The analysis of quantitative expression of somatostatin and dopamine receptors in gastro-entero-pancreatic tumours opens new therapeutic strategies.

A. Barlier, P. Ruszniewski, A. Couvelard, 2006, European journal of endocrinology.

[Transsphenoidal surgery in hypersecreting pituitary tumors: endocrine follow-up (author's transl)].

J. Lissitzky, F. Grisoli, P. Jaquet, 1978, Annales d'endocrinologie.